Skip to main content
Voronoi, Inc. logo

Voronoi, Inc. — Investor Relations & Filings

Ticker · 310210 ISIN · KR7310210000 KO Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2024-09-25 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 310210

About Voronoi, Inc.

https://voronoi.io

Voronoi, Inc. is a biotechnology company that specializes in the research and development of novel therapeutics for challenging diseases. The company's core expertise lies in creating innovative small molecule kinase inhibitors and target protein degrader drugs. Utilizing its proprietary AI-powered drug discovery platform, VORONOMICS, Voronoi accelerates the identification and optimization of promising drug candidates. This platform enables the rapid design of therapies with high selectivity and brain penetration, primarily targeting various forms of cancer and other difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
주식매수선택권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from Voronoi regarding the exercise of stock options (주식매수선택권행사). It details the number of shares exercised, the exercise price, the impact on total shares outstanding, and the specific individuals (directors and employees) involved in the transaction. This type of disclosure regarding the issuance of new shares resulting from stock option exercises is classified as a 'Share Issue/Capital Change' (SHA) filing.
2024-09-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. It details the shareholding changes of a specific executive (Kim Daekwon) of Voronoi Inc. This type of filing is a standard regulatory requirement for insider trading/shareholding disclosures, which corresponds to the 'Director's Dealing' category.
2024-09-25 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service (FSS). This type of filing is a mandatory disclosure for corporate insiders (directors/executives) reporting their personal share transactions, such as stock options exercises or open-market sales. According to the provided definitions, this corresponds to 'Director's Dealing' (DIRS).
2024-09-25 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders and special related parties, including reasons for changes such as stock option exercises and market sales. This corresponds to the 'Major Shareholding Notification' category.
2024-09-25 Korean
투자판단관련주요경영사항 (VRN04 프로그램 연구에 대한 옵션 계약 체결)
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Voronoi) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항). It details a specific business contract (an option agreement for the VRN04 research program) with a US-based company, Anvia Therapeutics, Inc. This type of disclosure regarding specific business contracts, partnerships, or licensing agreements that do not fit into specific categories like M&A or capital changes is best classified as a general regulatory filing (RNS).
2024-08-26 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (a corporate presentation). It specifies the date, location, purpose, and participants of the event. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into other specific categories like earnings releases or financial reports, it is classified as a Regulatory Filing (RNS) as it serves as a general corporate disclosure.
2024-08-19 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.